# Northwest Biotherapeutics Inc: Form 8-K, filed Jan 6, 2023

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 8-K
- Filed: 2023-01-06
- Accepted by EDGAR: Jan 6, 2023, 16:41 ET
- Period: 2022-12-30
- Accession: 0001104659-23-001886
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/tm231540d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/tm231540d1_8k.htm

Filed Jan 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-001886. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.